esmolol   Click here for help

GtoPdb Ligand ID: 7178

Synonyms: Brevibloc® | SL-8052
Approved drug
esmolol is an approved drug (FDA (1986))
Compound class: Synthetic organic
Comment: Esmolol is a β-blocker.
Marketed formulations may contain esmolol hydrochloride (PubChem CID 104769).
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: esmolol

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 10
Topological polar surface area 67.79
Molecular weight 295.18
XLogP 1.68
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O
Isomeric SMILES COC(=O)CCc1ccc(cc1)OCC(CNC(C)C)O
InChI InChI=1S/C16H25NO4/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3
InChI Key AQNDDEOPVVGCPG-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Esmolol is indicated for the treatment of acute supraventricular tachycardia, atrial fibrillation or atrial flutter.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Esmolol anatgonises β1-adrenoceptors in the sympathetic system. This prevents the receptors from processing signals from endogenous epinephrine and norepinephrine resulting in decreased force of heart contractions and lowered heart rate. See the DrugBank link for further details.
External links Click here for help